Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: Transplant centers’ prophylaxis and monitoring strategies: a key determinant of current herpes and polyomavirus incidences – results from the DZIF kidney transplant cohort

Fig. 2

Cumulative-incidence-rates of a) acute rejection in viremic and non-viremic patients. Cumulative-incidence-rates were compared to cumulative-incidence-rates of non-viremic patients (CMV-, BKV-, CMV-/BKV-, other herpes viruses-, respectively) using Gray-test. Other herpes viruses included HSV-1 (n = 15), HSV-2 (n = 6), VZV (n = 9), EBV (n = 5), HHV-6 (n = 1). Abbreviations: CMV=Cytomegalovirus, BKV = BK-virus, HSV=Herpes simplex virus, VZV = Varicella zoster virus, EBV = Epstein-Barr-virus and HHV-6 = Human Herpesvirus 6. b) infected patients experiencing rejection subsequent to infection (left side) or prior to infection (right side). Abbreviations: BPAR=biopsy proven acute rejection, TCMR=T-cell-mediated acute rejection, ABMR = Antibody-mediated acute rejection

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us